These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 28570241
41. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter. Obata JE, Nakamura T, Kitta Y, Saito Y, Sano K, Fujioka D, Kawabata K, Kugiyama K. Catheter Cardiovasc Interv; 2013 Nov 15; 82(6):E777-87. PubMed ID: 23378231 [Abstract] [Full Text] [Related]
44. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K, Mehilli J, Byrne RA, Schulz S, Massberg S, Laugwitz KL, Vorpahl M, Seyfarth M, Kastrati A, ISAR-LEFT MAIN Study Investigators. JACC Cardiovasc Interv; 2014 Jan 15; 7(1):29-36. PubMed ID: 24332416 [Abstract] [Full Text] [Related]
45. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients. Remkes WS, Somi S, Roolvink V, Rasoul S, Ottervanger JP, Gosselink AT, Hoorntje JC, Dambrink JH, de Boer MJ, Suryapranata H, van 't Hof AW, Acute Myocardial Infarction Study Group. JACC Cardiovasc Interv; 2014 Jul 15; 7(7):751-8. PubMed ID: 25060017 [Abstract] [Full Text] [Related]
47. The AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusion (ACE-CTO) Study. Kotsia A, Navara R, Michael TT, Sherbet DP, Roesle M, Christopoulos G, Rangan BV, Haagen D, Garcia S, Maniu C, Pershad A, Abdullah SM, Hastings JL, Kumbhani DJ, Luna M, Addo T, Banerjee S, Brilakis ES. J Invasive Cardiol; 2015 Sep 15; 27(9):393-400. PubMed ID: 26332874 [Abstract] [Full Text] [Related]
48. Restenosis after percutaneous coronary intervention for coronary chronic total occlusion. The central role of an optimized immediate post-procedural angiographic result. Isaaz K, Gerbay A, Terreaux J, Khamis H, Tammam K, Richard L, Cerisier A, Lamaud M, Da Costa A. Int J Cardiol; 2016 Dec 01; 224():343-347. PubMed ID: 27681251 [Abstract] [Full Text] [Related]
54. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study. Sabbah M, Kadota K, El-Eraky A, Kamal HM, Abdellah AT, El Hawary A. Int J Cardiovasc Imaging; 2017 Oct 01; 33(10):1463-1472. PubMed ID: 28444549 [Abstract] [Full Text] [Related]
55. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation. Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ. Catheter Cardiovasc Interv; 2014 May 01; 83(6):873-8. PubMed ID: 22815193 [Abstract] [Full Text] [Related]
56. Multivessel stent thrombosis with optical coherence tomography (OCT) utilization for therapeutic guidance. Yager N, Majithia A, Waxman S. Cardiovasc Revasc Med; 2017 Sep 01; 18(6):445-446. PubMed ID: 28404227 [Abstract] [Full Text] [Related]